Docket Room.
HR 166·AL·house

Encouraging the Alabama Medicaid Agency to evaluate the overall costs of GLP-1 medications and report its findings

FailedFiled Feb 24, 2026
Sponsor: Oliver
Latest Action

Pending Committee Action in House of Origin

Feb 24, 2026

Email me when HR 166 moves

Committee action, floor votes, amendments and hearings. Free, no card, no password.

Already have an account? Track HR 166. By continuing you agree to the Terms and Privacy Policy.

Summary

The resolution asks the Alabama Medicaid Agency to evaluate the overall cost of providing GLP‑1 medications for weight management, consider potential savings from new federal drug‑pricing models, and discuss findings with providers. It would affect roughly 110,000 Medicaid adults and children who might qualify for these drugs and aims to guide future coverage decisions. The agency must deliver a report to the Legislature before the 2027 session.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about HR 166

3 free questions a day, no account

History

  1. Read for the first time and referred to the House Committee on Rules
  2. Pending Committee Action in House of Origin (Rules)

Sponsors

  • Oliver · sponsor

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when HR 166 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track HR 166 free

Or ask your AI assistant about HR 166 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice